secwatch.observer — SEC 8-K summary
======================================

Issuer:     Altimmune, Inc. (ALT)
CIK:        0001326190
Form:       8-K
Filed at:   2024-08-15T23:59:59+00:00
Accession:  0001326190-24-000036
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Altimmune director David Drutz will not stand for re-election at 2024 annual meeting
--------------------------------------------------------------------------------

- David J. Drutz, M.D. notified the Board that he will not stand for re-election at the 2024 Annual Meeting of Shareholders.
- Drutz will continue as a director until the date of the Annual Meeting; his decision is not due to any disagreement with the company.
- The Board thanked Dr. Drutz for his service; no replacement has been announced as he will not stand for re-election.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326190/000132619024000036/0001326190-24-000036-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326190/000132619024000036/alt-20240813x8k.htm
  HTML page:      https://secwatch.observer/filing/0001326190-24-000036

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer